Welcome to our dedicated page for Viemed Healthcare news (Ticker: VMD), a resource for investors and traders seeking the latest updates and insights on Viemed Healthcare stock.
The Viemed Healthcare, Inc. (VMD) news page on Stock Titan aggregates company-specific updates for investors and observers who follow in-home post-acute respiratory care and home medical equipment providers. Viemed’s public communications describe it as a national leader in technology-enabled, in-home clinical care focused on non-invasive ventilation and related respiratory therapies in the United States.
News items for Viemed commonly include quarterly and year-to-date financial results, where the company reports revenue, net income, adjusted EBITDA, cash flow, and balance sheet data. These earnings releases, often furnished to the SEC on Form 8-K, are accompanied by financial supplements and sometimes updated full-year guidance ranges. They also highlight trends in ventilator, PAP therapy, and sleep resupply patient counts, as well as commentary from management on operating performance.
Another important category of news involves strategic transactions and capital allocation. Recent press releases have covered the authorization and completion of a share repurchase program, including the total number of shares repurchased and aggregate purchase price. Viemed has also announced the completion of its acquisition of Lehan’s Medical Equipment, an Illinois-based provider of home medical equipment with a focus on women’s health products and respiratory devices, and has discussed how this acquisition fits within its broader platform.
Visitors to this page can also expect updates about credit facility amendments, investor presentations, and conference appearances, which are often disclosed through Form 8-K filings and press releases. Together, these news items provide a view into Viemed’s operating trends, service diversification, financing arrangements, and outreach to the investment community. For anyone tracking VMD, this page serves as a centralized feed of the company’s official announcements and related coverage.
Viemed Healthcare (NASDAQ:VMD) reported strong Q2 2025 financial results, with record net revenues of $63.1 million, up 14.7% year-over-year. Net income reached $3.2 million ($0.08 per diluted share), a 115.1% increase from Q2 2024. The company's Adjusted EBITDA grew 11.5% to $14.3 million.
Operational highlights include significant patient growth, with ventilator patients up 11.4% to 12,152 and PAP therapy patients increasing 51.4% to 26,260. The company completed a $26 million acquisition of Lehan's Medical Equipment on July 1, 2025. Viemed raised its 2025 guidance, now expecting revenue between $271-277 million and Adjusted EBITDA of $59-62 million.
The company maintains a strong financial position with $20 million in cash and $55 million available in credit facilities.
Viemed Healthcare (NASDAQ:VMD), a provider of post-acute respiratory healthcare equipment and services in the United States, has scheduled its Second Quarter 2025 Earnings Conference Call for Thursday, August 7, 2025, at 11:00 a.m. EDT.
Participants can join via phone using US Toll-Free (877) 407-6176 or International +1 (201) 689-8451. A live audio webcast will be available, and a replay will be accessible through the company's investor relations website after the call.
Viemed Healthcare (NASDAQ:VMD) has completed the acquisition of Illinois-based Lehan's Medical Equipment for a base purchase price of $26 million, plus estimated contingent payments of $2.2 million. Lehan, with an 80-year history, generated $25.7 million in net revenues and $7.4 million in Adjusted EBITDA in 2024.
The acquisition strengthens Viemed's presence in post-acute respiratory healthcare, adding Lehan's three full-service locations in Northern Illinois and three sleep/CPAP setup locations in West Chicagoland and Wisconsin. Viemed plans to update its full-year 2025 guidance to reflect the acquisition's contribution when reporting Q2 2025 results.
[ "Acquisition adds $25.7M in revenue and $7.4M in Adjusted EBITDA from Lehan's 2024 performance", "Expands geographical footprint with 6 new locations in Illinois and Wisconsin", "Gains access to Lehan's preferred contracts and 80-year brand recognition", "Enhances service offerings with addition of women's health products and CPAP services" ]Viemed Healthcare (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, has announced its upcoming First Quarter 2025 Earnings Conference Call. The call is scheduled for Thursday, May 8, 2025, at 11:00 a.m. EDT.
Participants can join via phone using US Toll-Free (866) 682-6100 or International +1 (862) 298-0702. A live audio webcast will be available, and a replay will be accessible in the Investor Relations section of Viemed's website after the call.
Viemed Healthcare (NASDAQ:VMD) reported record financial results for Q4 and full-year 2024. The company achieved Q4 net revenues of $60.7 million, up 20% year-over-year, while full-year revenues reached $224.3 million, increasing 23% from 2023.
Q4 net income was $4.3 million ($0.10 per diluted share), up 24% YoY, with full-year net income at $11.3 million ($0.28 per diluted share), marking the eighth consecutive year of profitability. The company expanded its patient base significantly, with ventilator patients up 14% to 11,795, PAP therapy patients up 43% to 21,338, and sleep resupply patients up 29% to 24,478.
For 2025, Viemed projects net revenue between $254-265 million and adjusted EBITDA of $54-58 million. The company maintains a strong financial position with $17.5 million in cash and $55 million available in credit facilities.
Viemed Healthcare (NASDAQ: VMD), a national leader in respiratory care and technology-enabled home medical equipment services, has announced its upcoming Year End 2024 earnings conference call. The call is scheduled for Tuesday, March 11, 2025, at 11:00 a.m. EDT.
Interested participants can join the call by dialing 877-407-6176 (US Toll-Free) or +1 201-689-8451 (International). A live audio webcast will also be available through a dedicated link.
Following the live call, a replay will be accessible in the Investor Relations section of Viemed's website at www.viemed.com. This announcement allows investors and analysts to prepare for the company's presentation of its financial results and performance for the full year 2024.